Personalizing therapy with targeted agents in non-small cell lung cancer.

Oncotarget · 2011 · PMC3260814 · PMID 21444946

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a nonsignificant trendno p-value reported

High EGFR gene copy number (30.8% of patients) was associated with a nonsignificant trend toward improved OS with gefitinib treatment and patients with EGFR mutations had higher RR than patients without (37.5% versus 2.6%) [ 30 ].

also in 5,406 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.